Butyrate Inhibits the HDAC8/NF-κB Pathway to Enhance Slc26a3 Expression and Improve the Intestinal Epithelial Barrier to Relieve Colitis
Kaixin Peng(Tongji Hospital), Qin Yu(Chongqing Jiaotong University), Siqi Xiao(Tongji Hospital), Hongbing Yu(University of British Columbia), C.-L. Li(Tongji Hospital), Suhong Xia(Center for Digestive and Liver Diseases)
Cited by 60
Related Papers
The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects
|Cell Death Discovery|2023|184
Short‐chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
|Journal of Gastroenterology and Hepatology|2022|58
The role of sphingosine-1-phosphate in autophagy and related disorders
|Cell Death Discovery|2023|40
Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation
|International Journal of Molecular Medicine|2017|24